Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients

•There are few data on incidence of pneumothorax/pneumomediastinum in COVID-19 ARDS•We collected data from 116 COVID-19 patients requiring mechanical ventilation•Incidence of pneumothorax/pneumomediastinum was 24%•Time from symptoms onset to intubation is a predictor of pneumothorax/pneumomediastinu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiothoracic and vascular anesthesia 2021-12, Vol.35 (12), p.3642-3651
Hauptverfasser: Belletti, Alessandro, Palumbo, Diego, Zangrillo, Alberto, Fominskiy, Evgeny V., Franchini, Stefano, Dell'Acqua, Antonio, Marinosci, Alessandro, Monti, Giacomo, Vitali, Giordano, Colombo, Sergio, Guazzarotti, Giorgia, Lembo, Rosalba, Maimeri, Nicolò, Faustini, Carolina, Pennella, Renato, Mushtaq, Junaid, Landoni, Giovanni, Scandroglio, Anna Mara, Dagna, Lorenzo, De Cobelli, Francesco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•There are few data on incidence of pneumothorax/pneumomediastinum in COVID-19 ARDS•We collected data from 116 COVID-19 patients requiring mechanical ventilation•Incidence of pneumothorax/pneumomediastinum was 24%•Time from symptoms onset to intubation is a predictor of pneumothorax/pneumomediastinum•95% of pneumothorax/pneumomediastinum patients had Macklin sign on CT scan To determine the incidence, predictors, and outcome of pneumothorax (PNX)/pneumomediastinum (PMD) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). Observational study. Tertiary-care university hospital. One hundred sixteen consecutive critically ill, invasively ventilated patients with COVID-19 ARDS. The authors collected demographic, mechanical ventilation, imaging, laboratory, and outcome data. Primary outcome was the incidence of PNX/PMD. Multiple logistic regression analyses were performed to identify predictors of PNX/PMD. PNX/PMD occurred in a total of 28 patients (24.1%), with 22 patients developing PNX (19.0%) and 13 developing PMD (11.2%). Mean time to development of PNX/PMD was 14 ± 11 days from intubation. The authors found no significant difference in mechanical ventilation parameters between patients who developed PNX/PMD and those who did not. Mechanical ventilation parameters were within recommended limits for protective ventilation in both groups. Ninety-five percent of patients with PNX/PMD had the Macklin effect (linear collections of air contiguous to the bronchovascular sheaths) on a baseline computed tomography scan, and tended to have a higher lung involvement at intensive care unit (ICU) admission (Radiographic Assessment of Lung Edema score 32.2 ± 13.4 v 18.7 ± 9.8 in patients without PNX/PMD, p = 0.08). Time from symptom onset to intubation and time from total bilirubin on day two after ICU admission were the only independent predictors of PNX/PMD. Mortality was 60.7% in patients who developed PNX/PMD versus 38.6% in those who did not (p = 0.04). PNX/PMD occurs frequently in COVID-19 patients with ARDS requiring mechanical ventilation, and is associated with increased mortality. Development of PNX/PMD seems to occur despite use of protective mechanical ventilation and has a radiologic predictor sign.
ISSN:1053-0770
1532-8422
1532-8422
DOI:10.1053/j.jvca.2021.02.008